AKZO NOBEL N.V. (AKZA.AS) Fundamental Analysis & Valuation

AMS:AKZA • NL0013267909

Current stock price

47.86 EUR
+0.56 (+1.18%)
Last:

This AKZA.AS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. AKZA.AS Profitability Analysis

1.1 Basic Checks

  • In the past year AKZA was profitable.
  • In the past year AKZA had a positive cash flow from operations.
  • Each year in the past 5 years AKZA has been profitable.
  • AKZA had a positive operating cash flow in each of the past 5 years.
AKZA.AS Yearly Net Income VS EBIT VS OCF VS FCFAKZA.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B 4B 6B

1.2 Ratios

  • Looking at the Return On Assets, with a value of 4.55%, AKZA is in the better half of the industry, outperforming 62.86% of the companies in the same industry.
  • With a decent Return On Equity value of 13.63%, AKZA is doing good in the industry, outperforming 74.29% of the companies in the same industry.
  • AKZA has a better Return On Invested Capital (8.24%) than 70.00% of its industry peers.
Industry RankSector Rank
ROA 4.55%
ROE 13.63%
ROIC 8.24%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
AKZA.AS Yearly ROA, ROE, ROICAKZA.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40 50

1.3 Margins

  • AKZA's Profit Margin of 6.25% is fine compared to the rest of the industry. AKZA outperforms 64.29% of its industry peers.
  • AKZA's Profit Margin has declined in the last couple of years.
  • AKZA has a Operating Margin of 11.46%. This is in the better half of the industry: AKZA outperforms 70.00% of its industry peers.
  • In the last couple of years the Operating Margin of AKZA has remained more or less at the same level.
  • AKZA has a Gross Margin (39.86%) which is in line with its industry peers.
  • In the last couple of years the Gross Margin of AKZA has declined.
Industry RankSector Rank
OM 11.46%
PM (TTM) 6.25%
GM 39.86%
OM growth 3Y20.63%
OM growth 5Y0.3%
PM growth 3Y24.42%
PM growth 5Y-3.28%
GM growth 3Y3.29%
GM growth 5Y-2.12%
AKZA.AS Yearly Profit, Operating, Gross MarginsAKZA.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. AKZA.AS Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so AKZA is still creating some value.
  • AKZA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
AKZA.AS Yearly Shares OutstandingAKZA.AS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
AKZA.AS Yearly Total Debt VS Total AssetsAKZA.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

  • An Altman-Z score of 2.22 indicates that AKZA is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • AKZA has a Altman-Z score (2.22) which is in line with its industry peers.
  • The Debt to FCF ratio of AKZA is 8.04, which is on the high side as it means it would take AKZA, 8.04 years of fcf income to pay off all of its debts.
  • AKZA's Debt to FCF ratio of 8.04 is in line compared to the rest of the industry. AKZA outperforms 51.43% of its industry peers.
  • A Debt/Equity ratio of 0.79 indicates that AKZA is somewhat dependend on debt financing.
  • AKZA has a worse Debt to Equity ratio (0.79) than 74.29% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.79
Debt/FCF 8.04
Altman-Z 2.22
ROIC/WACC1.24
WACC6.63%
AKZA.AS Yearly LT Debt VS Equity VS FCFAKZA.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B 4B 6B 8B 10B

2.3 Liquidity

  • AKZA has a Current Ratio of 1.44. This is a normal value and indicates that AKZA is financially healthy and should not expect problems in meeting its short term obligations.
  • The Current ratio of AKZA (1.44) is worse than 61.43% of its industry peers.
  • A Quick Ratio of 1.08 indicates that AKZA should not have too much problems paying its short term obligations.
  • AKZA has a Quick ratio (1.08) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 1.44
Quick Ratio 1.08
AKZA.AS Yearly Current Assets VS Current LiabilitesAKZA.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. AKZA.AS Growth Analysis

3.1 Past

  • AKZA shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -6.43%.
  • Measured over the past years, AKZA shows a decrease in Earnings Per Share. The EPS has been decreasing by -1.32% on average per year.
  • Looking at the last year, AKZA shows a decrease in Revenue. The Revenue has decreased by -5.16% in the last year.
  • The Revenue has been growing slightly by 3.56% on average over the past years.
EPS 1Y (TTM)-6.43%
EPS 3Y14.42%
EPS 5Y-1.32%
EPS Q2Q%0%
Revenue 1Y (TTM)-5.16%
Revenue growth 3Y-2.16%
Revenue growth 5Y3.56%
Sales Q2Q%-9.43%

3.2 Future

  • Based on estimates for the next years, AKZA will show a quite strong growth in Earnings Per Share. The EPS will grow by 14.14% on average per year.
  • Based on estimates for the next years, AKZA will show a small growth in Revenue. The Revenue will grow by 6.43% on average per year.
EPS Next Y15.8%
EPS Next 2Y13.09%
EPS Next 3Y10.75%
EPS Next 5Y14.14%
Revenue Next Year-2.92%
Revenue Next 2Y-0.21%
Revenue Next 3Y1.7%
Revenue Next 5Y6.43%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
AKZA.AS Yearly Revenue VS EstimatesAKZA.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5B 10B 15B
AKZA.AS Yearly EPS VS EstimatesAKZA.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6

More info and screens

Find the best growth stocksShow best growing peers

6

4. AKZA.AS Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 13.15, the valuation of AKZA can be described as correct.
  • Compared to the rest of the industry, the Price/Earnings ratio of AKZA indicates a somewhat cheap valuation: AKZA is cheaper than 78.57% of the companies listed in the same industry.
  • AKZA is valuated rather cheaply when we compare the Price/Earnings ratio to 25.23, which is the current average of the S&P500 Index.
  • AKZA is valuated reasonably with a Price/Forward Earnings ratio of 11.35.
  • 84.29% of the companies in the same industry are more expensive than AKZA, based on the Price/Forward Earnings ratio.
  • The average S&P500 Price/Forward Earnings ratio is at 23.28. AKZA is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 13.15
Fwd PE 11.35
AKZA.AS Price Earnings VS Forward Price EarningsAKZA.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • 68.57% of the companies in the same industry are more expensive than AKZA, based on the Enterprise Value to EBITDA ratio.
  • 78.57% of the companies in the same industry are more expensive than AKZA, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 13.53
EV/EBITDA 6.96
AKZA.AS Per share dataAKZA.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.83
PEG (5Y)N/A
EPS Next 2Y13.09%
EPS Next 3Y10.75%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

4

5. AKZA.AS Dividend Analysis

5.1 Amount

  • AKZA has a Yearly Dividend Yield of 3.78%.
  • Compared to an average industry Dividend Yield of 2.38, AKZA pays a bit more dividend than its industry peers.
  • Compared to an average S&P500 Dividend Yield of 1.91, AKZA pays a better dividend.
Industry RankSector Rank
Dividend Yield 3.78%

5.2 History

  • The dividend of AKZA decreases each year by -21.52%.
Dividend Growth(5Y)-21.52%
Div Incr Years0
Div Non Decr Years4
AKZA.AS Yearly Dividends per shareAKZA.AS Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 2026 2 4 6

5.3 Sustainability

  • AKZA pays out 60.16% of its income as dividend. This is not a sustainable payout ratio.
DP60.16%
EPS Next 2Y13.09%
EPS Next 3Y10.75%
AKZA.AS Yearly Income VS Free CF VS DividendAKZA.AS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B 4B 6B
AKZA.AS Dividend Payout.AKZA.AS Dividend Payout, showing the Payout Ratio.AKZA.AS Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

AKZA.AS Fundamentals: All Metrics, Ratios and Statistics

AKZO NOBEL N.V.

AMS:AKZA (3/20/2026, 7:00:00 PM)

47.86

+0.56 (+1.18%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)02-03
Earnings (Next)04-21
Inst Owners89.53%
Inst Owner ChangeN/A
Ins Owners0.04%
Ins Owner ChangeN/A
Market Cap8.19B
Revenue(TTM)10.16B
Net Income(TTM)635.00M
Analysts77.6
Price Target69.17 (44.53%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.78%
Yearly Dividend1.98
Dividend Growth(5Y)-21.52%
DP60.16%
Div Incr Years0
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-20.39%
Min EPS beat(2)-33.37%
Max EPS beat(2)-7.4%
EPS beat(4)0
Avg EPS beat(4)-12.83%
Min EPS beat(4)-33.37%
Max EPS beat(4)-4.18%
EPS beat(8)1
Avg EPS beat(8)-7.59%
EPS beat(12)2
Avg EPS beat(12)-8.15%
EPS beat(16)3
Avg EPS beat(16)-13.47%
Revenue beat(2)0
Avg Revenue beat(2)-2.49%
Min Revenue beat(2)-4.05%
Max Revenue beat(2)-0.93%
Revenue beat(4)0
Avg Revenue beat(4)-3.08%
Min Revenue beat(4)-5.13%
Max Revenue beat(4)-0.93%
Revenue beat(8)1
Avg Revenue beat(8)-1.97%
Revenue beat(12)3
Avg Revenue beat(12)-1.59%
Revenue beat(16)3
Avg Revenue beat(16)-1.66%
PT rev (1m)-1.09%
PT rev (3m)-1.18%
EPS NQ rev (1m)-5.4%
EPS NQ rev (3m)-15.34%
EPS NY rev (1m)-3.9%
EPS NY rev (3m)-7.49%
Revenue NQ rev (1m)-1.17%
Revenue NQ rev (3m)-7.96%
Revenue NY rev (1m)-2.54%
Revenue NY rev (3m)-2.94%
Valuation
Industry RankSector Rank
PE 13.15
Fwd PE 11.35
P/S 0.81
P/FCF 13.53
P/OCF 8.96
P/B 1.76
P/tB 9.51
EV/EBITDA 6.96
EPS(TTM)3.64
EY7.61%
EPS(NY)4.22
Fwd EY8.81%
FCF(TTM)3.54
FCFY7.39%
OCF(TTM)5.34
OCFY11.16%
SpS59.39
BVpS27.24
TBVpS5.03
PEG (NY)0.83
PEG (5Y)N/A
Graham Number47.23
Profitability
Industry RankSector Rank
ROA 4.55%
ROE 13.63%
ROCE 11.94%
ROIC 8.24%
ROICexc 10.26%
ROICexgc 19.94%
OM 11.46%
PM (TTM) 6.25%
GM 39.86%
FCFM 5.96%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y20.63%
OM growth 5Y0.3%
PM growth 3Y24.42%
PM growth 5Y-3.28%
GM growth 3Y3.29%
GM growth 5Y-2.12%
F-Score5
Asset Turnover0.73
Health
Industry RankSector Rank
Debt/Equity 0.79
Debt/FCF 8.04
Debt/EBITDA 2.38
Cap/Depr 81.75%
Cap/Sales 3.04%
Interest Coverage 7.19
Cash Conversion 59.27%
Profit Quality 95.28%
Current Ratio 1.44
Quick Ratio 1.08
Altman-Z 2.22
F-Score5
WACC6.63%
ROIC/WACC1.24
Cap/Depr(3y)81.45%
Cap/Depr(5y)81.15%
Cap/Sales(3y)2.86%
Cap/Sales(5y)2.86%
Profit Quality(3y)116.92%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-6.43%
EPS 3Y14.42%
EPS 5Y-1.32%
EPS Q2Q%0%
EPS Next Y15.8%
EPS Next 2Y13.09%
EPS Next 3Y10.75%
EPS Next 5Y14.14%
Revenue 1Y (TTM)-5.16%
Revenue growth 3Y-2.16%
Revenue growth 5Y3.56%
Sales Q2Q%-9.43%
Revenue Next Year-2.92%
Revenue Next 2Y-0.21%
Revenue Next 3Y1.7%
Revenue Next 5Y6.43%
EBIT growth 1Y26.94%
EBIT growth 3Y18.02%
EBIT growth 5Y3.86%
EBIT Next Year33.57%
EBIT Next 3Y15.49%
EBIT Next 5Y23.47%
FCF growth 1Y67.13%
FCF growth 3YN/A
FCF growth 5Y-8.8%
OCF growth 1Y36.83%
OCF growth 3Y53.24%
OCF growth 5Y-5.57%

AKZO NOBEL N.V. / AKZA.AS Fundamental Analysis FAQ

What is the ChartMill fundamental rating of AKZO NOBEL N.V. (AKZA.AS) stock?

ChartMill assigns a fundamental rating of 4 / 10 to AKZA.AS.


What is the valuation status for AKZA stock?

ChartMill assigns a valuation rating of 6 / 10 to AKZO NOBEL N.V. (AKZA.AS). This can be considered as Fairly Valued.


What is the profitability of AKZA stock?

AKZO NOBEL N.V. (AKZA.AS) has a profitability rating of 5 / 10.


What is the financial health of AKZO NOBEL N.V. (AKZA.AS) stock?

The financial health rating of AKZO NOBEL N.V. (AKZA.AS) is 3 / 10.


What is the earnings growth outlook for AKZO NOBEL N.V.?

The Earnings per Share (EPS) of AKZO NOBEL N.V. (AKZA.AS) is expected to grow by 15.8% in the next year.